New ask Hacker News story: Ask HN: Personalized mRNA cancer vaccines, how real is the pipeline today?
Ask HN: Personalized mRNA cancer vaccines, how real is the pipeline today?
4 by imnotlost | 2 comments on Hacker News.
I came across this open-source workflow for designing personalized mRNA cancer vaccines: https://philfung.github.io/openvaxx/ And this recent story about a man who worked with researchers to create a personalized cancer vaccine for his dog: https://ift.tt/e5wWFJQ It got me wondering what the current technology, research, and startup landscape looks like for personalized mRNA medicine in humans. Are any HN people working in this space, or close to it? I’m especially curious about: - how real the pipeline is today outside major institutions - which parts are getting cheaper or more accessible - which parts of the pipeline is being taken over by software and possibly new AI models - where the real bottlenecks are: sequencing, target selection, manufacturing, QC, regulation, or something else - whether anyone is building tools, infrastructure, or startups around more individualized mRNA therapies
4 by imnotlost | 2 comments on Hacker News.
I came across this open-source workflow for designing personalized mRNA cancer vaccines: https://philfung.github.io/openvaxx/ And this recent story about a man who worked with researchers to create a personalized cancer vaccine for his dog: https://ift.tt/e5wWFJQ It got me wondering what the current technology, research, and startup landscape looks like for personalized mRNA medicine in humans. Are any HN people working in this space, or close to it? I’m especially curious about: - how real the pipeline is today outside major institutions - which parts are getting cheaper or more accessible - which parts of the pipeline is being taken over by software and possibly new AI models - where the real bottlenecks are: sequencing, target selection, manufacturing, QC, regulation, or something else - whether anyone is building tools, infrastructure, or startups around more individualized mRNA therapies
Comments
Post a Comment